Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
Tae Kon KimMina L XuNikolai A PodoltsevThomas PrebetLisa BarbarottaKejal AminStephanie KasbergKristen RocheMaximilian StahlSteven D GoreAmer M ZeidanPublished in: Annals of hematology (2016)